Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Journey Med Corp (DERM)

71 + Investors. Track Smart Money conviction in DERM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
→ 0
Streak
1Q —
Buyers last Q
48%

Smart Money Signals — DERM

Based on 71 hedge funds · latest filing: 2026 Q2 · updated quarterly

➡️

No change last quarter

last 6Q
The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.
📊

High ownership — 93% of 3.0Y peak

93% of all-time peak
71 funds currently hold this stock — 93% of the 3.0-year high of 76 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +27% more funds vs a year ago

fund count last 6Q
+15 new funds entered over the past year (+27% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 48% buying

44 buying47 selling
Last quarter: 47 funds reduced or exited vs 44 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
📈

More new buyers each quarter (+12 vs last Q)

new funds entering per quarter
Funds opening a new DERM position: 15 → 18 → 13 → 25. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

51% of holders stayed for 2+ years

■ 51% conviction (2yr+) ■ 17% medium ■ 32% new
36 out of 71 hedge funds have held DERM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Price up while funds trimmed (+35% value, -10% shares)

Value
+35%
Shares
-9%
Last quarter: total value of institutional DERM holdings rose +35% even though funds reduced share count by 10%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
📈

Growing discovery — still being found

25 → 15 → 18 → 13 → 25 new funds/Q
New funds entering each quarter: 15 → 18 → 13 → 25. A growing number of institutions are discovering DERM each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 57% veterans vs 33% newcomers

■ 57% veterans ■ 10% 1-2yr ■ 33% new
Entry-cohort mix of 72 holders: 41 (57%) are 2+ year veterans, 7 entered 1–2 years ago, and 24 (33%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 10% AUM from top-100

10% from top-100 AUM funds
22 of 71 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.7
out of 10
Low Exit Risk
Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DERM

In 2026 Q2, 44 hedge funds were net buyers of DERM (25 opened a new position, 19 added to an existing one), while 47 reduced or exited (22 trimmed, 25 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. Net fund flow last quarter: flat (entries and exits balanced). Total institutional holders: 71.

Hedge Fund Ownership: DERM

How many hedge funds hold DERM — quarterly history vs. share price
Quarterly hedge fund ownership of DERM vs. share price

Market Analysis: DERM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DERM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Journey Med Corp (DERM) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much DERM has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 59d ago
DERM
+6.4%
XLV
+7.8%

DERM outperformed XLV by -1.4% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 14d ago
DERM
+12.1%
XLV
+2.2%

Since the filing became public, DERM outperformed XLV by +9.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.3
/ 10
conviction
Hedge Fund Positioning: DERM
71 + Investors

Track Smart Money conviction in DERM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 71 71 -
13F Shares 11M 12M -9.86%
Total Value $76M $56M 35.48%
New Positions 25 13 +12
Increased Positions 19 31 -12
Closed Positions 25 18 +7
Reduced Positions 22 18 +4
Total Calls 1 0 100%
Total Puts 0 1 -100.0%
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: DERM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

71 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DERM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 DERM holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Tang Capital Management LLC 0.52% 1,610,000 $11.4M
2 American Financial Group Inc 0.45% 180,000 $1.3M
3 Pvg Asset Management Corp 0.33% 79,573 $563K
4 Pale Fire Capital SE 0.26% 528,584 $3.7M
5 Opaleye Management Inc. 0.22% 350,000 $2.5M
6 Diametric Capital, LP 0.22% 295,663 $2.1M
7 Ikarian Capital, LLC 0.19% 251,436 $1.8M
8 Punch & Associates Investment Management, INC. 0.19% 536,000 $3.8M
9 Wasatch Advisors LP 0.13% 2,858,930 $20.2M
10 Frec Markets, Inc. 0.03% 50,500 $358K
11 Summit Financial, LLC 0.03% 346,748 $2.5M
12 J. Goldman & Co LP 0.03% 137,584 $974K
13 Persistent Asset Partners Ltd 0.02% 10,082 $71K
14 ADAR1 Capital Management, LLC 0.01% 39,517 $280K
15 Arete Wealth Advisors, LLC 0.01% 51,792 $367K
16 Prelude Capital Management, LLC 0.01% 21,905 $155K
17 XTX Topco Ltd 0.01% 100,923 $715K
18 Geneos Wealth Management Inc. 0.01% 63,280 $448K
19 Trexquant Investment LP 0.01% 171,338 $1.2M
20 Boothbay Fund Management, LLC 0.01% 67,442 $477K
21 Salem Investment Counselors Inc 0.01% 29,200 $207K
22 Gladstone Institutional Advisory LLC 0.00% 20,000 $142K
23 Integrated Wealth Concepts LLC 0.00% 78,928 $559K
24 Renaissance Technologies LLC 0.00% 229,700 $1.6M
25 Quadrature Capital Ltd 0.00% 28,841 $204K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Journey Med Corp (DERM)

What does the Smart Money Trend signal show for DERM?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for DERM?

More sellers than buyers — 48% buying: Last quarter: 47 funds reduced or exited vs 44 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for DERM holders?

Smaller funds dominant — 10% AUM from top-100: 22 of 71 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held DERM?

51% of holders stayed for 2+ years: 36 out of 71 hedge funds have held DERM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Journey Med Corp (DERM) following the 2026 Q2 hedge fund 13F filings?

As of today, DERM has moved +12.1% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.2% for the XLV sector ETF — an outperformance of +9.9%. Since the quarter end (June 30, 2026), DERM has gained +6.4% vs +7.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →